Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)
Authors
Keywords
Breast cancer, Tumor-stroma, Prognosis, Node-negative, Pre-menopausal, Validation study
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 139, Issue 2, Pages 371-379
Publisher
Springer Nature
Online
2013-05-24
DOI
10.1007/s10549-013-2571-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The prognostic role of TGF-β signaling pathway in breast cancer patients
- (2012) E. M. de Kruijf et al. ANNALS OF ONCOLOGY
- Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
- (2012) Douglas G Altman et al. BMC Medicine
- Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients
- (2010) Esther M. de Kruijf et al. BREAST CANCER RESEARCH AND TREATMENT
- The stromal part of adenocarcinomas of the oesophagus: Does it conceal targets for therapy?
- (2010) Ewout F.W. Courrech Staal et al. EUROPEAN JOURNAL OF CANCER
- Hallmarks of cancer: Interactions with the tumor stroma
- (2010) Kristian Pietras et al. EXPERIMENTAL CELL RESEARCH
- Stromal CD10 expression and relationship to the E-cadherin/β-catenin complex in breast carcinoma
- (2010) Hyun-Soo Kim et al. HISTOPATHOLOGY
- Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20
- (2010) Eleftherios P. Mamounas et al. JOURNAL OF CLINICAL ONCOLOGY
- The molecular pathology of breast cancer progression
- (2010) Alessandro Bombonati et al. JOURNAL OF PATHOLOGY
- Interactions with Fibroblasts Are Distinct in Basal-Like and Luminal Breast Cancers
- (2010) J. T. Camp et al. MOLECULAR CANCER RESEARCH
- An Absence of Stromal Caveolin-1 Expression Predicts Early Tumor Recurrence and Poor Clinical Outcome in Human Breast Cancers
- (2009) Agnieszka K. Witkiewicz et al. AMERICAN JOURNAL OF PATHOLOGY
- Activation of Host Wound Responses in Breast Cancer Microenvironment
- (2009) M. A. Troester et al. CLINICAL CANCER RESEARCH
- Prognosis After Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Patients Treated by Breast-Conserving Therapy in Five National Surgical Adjuvant Breast and Bowel Project Protocols of Node-Negative Breast Cancer
- (2009) Stewart J. Anderson et al. JOURNAL OF CLINICAL ONCOLOGY
- A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
- (2009) Pierre Farmer et al. NATURE MEDICINE
- The fibromatosis signature defines a robust stromal response in breast carcinoma
- (2008) Andrew H Beck et al. LABORATORY INVESTIGATION
- Stromal gene expression predicts clinical outcome in breast cancer
- (2008) Greg Finak et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started